Skip to main content
Figure 4 | BMC Gastroenterology

Figure 4

From: Retreatment of hepatitis C non-responsive to Interferon. A placebo controlled randomized trial of Ribavirin monotherapy versus combination therapy with Ribavirin and Interferon in 121 patients in the Benelux [ISRCTN53821378]

Figure 4

Cumulative probability of ALT response during treatment. Patients treated with combination therapy in this trial vs results of the same patients in a previous trial with interferon monotherapy [4]. There is a trend towards increased normalisation rate with interferon and ribavirin combination therapy.

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us